275 related articles for article (PubMed ID: 28653264)
1. Survival analysis of patients with systemic lupus erythematosus in a tertiary hospital in southern Brazil.
Hendler JV; de Souza L; de Freitas Zernow DC; Guimarães J; Bertotto T; Saldanha CF; Brenol JCT; Monticielo OA
Clin Rheumatol; 2017 Sep; 36(9):2005-2010. PubMed ID: 28653264
[TBL] [Abstract][Full Text] [Related]
2. Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus.
Rúa-Figueroa Í; López-Longo J; Galindo-Izquierdo M; Calvo-Alén J; Del Campo V; Olivé-Marqués A; Pérez-Vicente S; Fernández-Nebro A; Andrés M; Erausquin C; Tomero E; Horcada L; Uriarte E; Freire M; Montilla C; Sánchez-Atrio A; Santos G; Boteanu A; Díez-Álvarez E; Narváez J; Martínez-Taboada V; Silva-Fernández L; Ruiz-Lucea E; Andreu JL; Hernández-Beriain JÁ; Gantes M; Hernández-Cruz B; Pérez-Venegas J; Pecondón-Español Á; Marras C; Ibáñez-Barceló M; Bonilla G; Torrente V; Castellví I; Alegre JJ; Calvet J; Marenco JL; Raya E; Vázquez T; Quevedo V; Muñoz-Fernández S; Rodríguez-Gómez M; Ibáñez J; Pego-Reigosa JM
Semin Arthritis Rheum; 2017 Aug; 47(1):38-45. PubMed ID: 28259425
[TBL] [Abstract][Full Text] [Related]
3. Good survival rates in systemic lupus erythematosus in southern Sweden, while the mortality rate remains increased compared with the population.
Ingvarsson RF; Landgren AJ; Bengtsson AA; Jönsen A
Lupus; 2019 Oct; 28(12):1488-1494. PubMed ID: 31551031
[TBL] [Abstract][Full Text] [Related]
4. Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom.
Lorenzo-Vizcaya A; Isenberg D
Lupus; 2021 Apr; 30(5):702-706. PubMed ID: 33472522
[TBL] [Abstract][Full Text] [Related]
5. Self-reported disease severity in women with systemic lupus erythematosus.
Dima A; Caraiola S; Delcea C; Ionescu RA; Jurcut C; Badea C
Rheumatol Int; 2019 Mar; 39(3):533-539. PubMed ID: 30415452
[TBL] [Abstract][Full Text] [Related]
6. Mortality in patients with systemic lupus erythematosus in Colombia: a case series.
Aguirre-Valencia D; Suárez-Avellaneda A; Ocampo-Piraquive V; Posso-Osorio I; Naranjo-Escobar J; Nieto-Aristizábal I; Tobón GJ; Cañas CA
Clin Rheumatol; 2019 Jul; 38(7):1865-1871. PubMed ID: 30989407
[TBL] [Abstract][Full Text] [Related]
7. Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.
Fasano S; Margiotta DPE; Pierro L; Navarini L; Riccardi A; Afeltra A; Valentini G
Clin Rheumatol; 2019 Feb; 38(2):457-463. PubMed ID: 30194649
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups.
Mok CC; Mak A; Chu WP; To CH; Wong SN
Medicine (Baltimore); 2005 Jul; 84(4):218-224. PubMed ID: 16010206
[TBL] [Abstract][Full Text] [Related]
9. Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus.
Ruiz-Irastorza G; Egurbide MV; Pijoan JI; Garmendia M; Villar I; Martinez-Berriotxoa A; Erdozain JG; Aguirre C
Lupus; 2006; 15(9):577-83. PubMed ID: 17080912
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage.
Brunner HI; Silverman ED; To T; Bombardier C; Feldman BM
Arthritis Rheum; 2002 Feb; 46(2):436-44. PubMed ID: 11840446
[TBL] [Abstract][Full Text] [Related]
11. Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome.
Williams FM; Chinn S; Hughes GR; Leach RM
Ann Rheum Dis; 2002 May; 61(5):414-21. PubMed ID: 11959765
[TBL] [Abstract][Full Text] [Related]
12. Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: data from a Latin American cohort.
Pons-Estel GJ; Alarcón GS; Burgos PI; Hachuel L; Boggio G; Wojdyla D; Nieto R; Alvarellos A; Catoggio LJ; Guibert-Toledano M; Sarano J; Massardo L; Vásquez GM; Iglesias-Gamarra A; Lavras Costallat LT; Da Silva NA; Alfaro JL; Abadi I; Segami MI; Huerta G; Cardiel MH; Pons-Estel BA;
Lupus; 2013 Aug; 22(9):899-907. PubMed ID: 23857989
[TBL] [Abstract][Full Text] [Related]
13. Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort.
Pimentel-Quiroz VR; Ugarte-Gil MF; Harvey GB; Wojdyla D; Pons-Estel GJ; Quintana R; Esposto A; García MA; Catoggio LJ; Cardiel MH; Barile LA; Amigo MC; Sato EI; Bonfa E; Borba E; Lavras Costallat LT; Neira OJ; Massardo L; Guibert-Toledano M; Chacón-Díaz R; Alarcón GS; Pons-Estel BA
Lupus; 2019 Aug; 28(9):1101-1110. PubMed ID: 31291843
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.
Hesselvig JH; Ahlehoff O; Dreyer L; Gislason G; Kofoed K
Lupus; 2017 Jan; 26(1):48-53. PubMed ID: 27235406
[TBL] [Abstract][Full Text] [Related]
15. Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes.
Rúa-Figueroa I; López-Longo FJ; Del Campo V; Galindo-Izquierdo M; Uriarte E; Torre-Cisneros J; Vela P; Tomero E; Narváez J; Olivé A; Freire M; Salgado E; Andreu JL; Martínez-Taboada V; Calvo-Alén J; Hernández-Cruz B; Raya E; Quevedo V; Expósito Pérez L; Fernández-Nebro A; Ibañez M; Pascual-Valls È; Rúa-Figueroa D; Naranjo A; Pego-Reigosa JM
J Rheumatol; 2020 Feb; 47(2):234-240. PubMed ID: 30988123
[TBL] [Abstract][Full Text] [Related]
16. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G
J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
[TBL] [Abstract][Full Text] [Related]
17. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis.
Feldman CH; Hiraki LT; Winkelmayer WC; Marty FM; Franklin JM; Kim SC; Costenbader KH
Arthritis Rheumatol; 2015 Jun; 67(6):1577-85. PubMed ID: 25772621
[TBL] [Abstract][Full Text] [Related]
18. Lupus disease activity and the risk of subsequent organ damage and mortality in a large lupus cohort.
Lopez R; Davidson JE; Beeby MD; Egger PJ; Isenberg DA
Rheumatology (Oxford); 2012 Mar; 51(3):491-8. PubMed ID: 22109798
[TBL] [Abstract][Full Text] [Related]
19. The pulse-mass index as a predictor of cardiovascular events in women with systemic lupus erythematosus.
García-Villegas EA; Márquez-González H; Flores-Suárez LF; Villa-Romero AR
Med Clin (Barc); 2017 Jan; 148(2):57-62. PubMed ID: 27865435
[TBL] [Abstract][Full Text] [Related]
20. Survival rates and risk factors for mortality in systemic lupus erythematosus patients in a Chinese center.
Wu G; Jia X; Gao D; Zhao Z
Clin Rheumatol; 2014 Jul; 33(7):947-53. PubMed ID: 24794488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
